|
Video: What is a Stock Split?
|
|
Sophiris Bio is a biopharmaceutical company focused on products for the treatment of urological diseases. Co. is developing topsalysin (PRX302) as a treatment for clinically significant localized prostate cancer and as a treatment for the lower urinary tract symptoms of benign prostatic hyperplasia, commonly referred to as an enlarged prostate. Topsalysin, a genetically modified recombinant protein, is delivered via ultrasound-guided injection directly into the prostate. This protein is selectively activated by enzymatically active prostate specific antigen, which is in the prostate, resulting in localized cell death and tissue disruption without damage to neighboring tissue and nerves. According to our SPHS split history records, SPHS has had 1 split. | |
|
SPHS (SPHS) has 1 split in our SPHS split history database. The split for SPHS took place on August 15, 2013. This was a 1 for 52 reverse split, meaning for each 52 shares of SPHS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 19.2307692307692 share position following the split.
When a company such as SPHS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SPHS split history from start to finish, an original position size of 1000 shares would have turned into 19.2307692307692 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SPHS shares, starting with a $10,000 purchase of SPHS, presented on a split-history-adjusted basis factoring in the complete SPHS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
09/29/2021 |
|
Start price/share: |
$3.48 |
|
End price/share: |
$0.01 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.71% |
|
Average Annual Total Return: |
-54.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$28.74 |
|
Years: |
7.44 |
|
|
|
Date |
Ratio |
08/15/2013 | 1 for 52 |
|
|